MNICF.US Mani, Inc.
- Market cap
- USD 1.26B
- P/E
- 30.5x
- P/B
- 3.40x
- ROE
- 13.1%
- Dividend yield
- 2.41%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to May 2026.
Is MNICF.US undervalued?
Graham numberMNICF.US trades 114.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mani, Inc. fundamental analysis
No fundamental analysis for Mani, Inc. yet.
Mani, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mani, Inc.
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also p…
Full company profileMani, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to May 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Mani, Inc. annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 15.2B | 17.2B | 20.4B | 24.5B | 28.5B | 30.0B | 32.5B |
| Gross Profit | 9.88B | 11.0B | 12.6B | 15.4B | 17.9B | 19.3B | 21.7B |
| Operating Income | 4.34B | 5.35B | 6.16B | 7.24B | 8.39B | 8.19B | 9.98B |
| EBITDA | - | - | 9.17B | 9.94B | 10.7B | 9.56B | 10.7B |
| Net Income | 3.33B | 4.29B | 5.29B | 5.95B | 6.29B | 4.64B | 7.52B |
| EPS | 34 | 44 | 54 | 60 | 64 | 47 | 76 |
| Balance Sheet | |||||||
| Total Assets | 39.3B | 42.7B | 50.1B | 55.0B | 57.2B | 58.0B | 62.5B |
| Total Liabilities | 2.72B | 3.49B | 4.70B | 5.15B | 4.85B | 4.43B | 5.23B |
| Shareholders' Equity | 36.6B | 39.2B | 45.4B | 49.8B | 52.3B | 53.6B | 57.2B |
| Cash & Short-term Investments | 17.2B | 18.3B | 22.7B | 25.4B | 21.6B | 18.4B | 23.8B |
| Cash Flow | |||||||
| Operating Cash Flow | 1.94B | 6.38B | 6.56B | 8.03B | 7.81B | 7.02B | - |
| Capital Expenditure | 1.69B | 3.86B | 1.94B | 3.72B | 7.68B | 6.67B | 0.00 |
| Free Cash Flow | 249M | 2.52B | 4.62B | 4.31B | 129M | 347M | - |
| Ratios | |||||||
| ROE | 9.1% | 10.9% | 11.6% | 11.9% | 12.0% | 8.7% | 13.1% |
| ROA | 8.5% | 10.1% | 10.6% | 10.8% | 11.0% | 8.0% | 12.0% |
| Net Profit Margin | 21.9% | 25.0% | 25.9% | 24.3% | 22.0% | 15.5% | 23.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Mani, Inc. dividends
- Dividend yield
- 2.41%
- Forward dividend
- 0.31 USD
- Payout ratio
- 82.7%
- Ex-dividend date
- Feb 25, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | JPY 3.84B | 39 | 82.7% |
| 2024 | JPY 3.65B | 37 | 58.0% |
| 2023 | JPY 3.15B | 32 | 52.9% |
| 2022 | JPY 2.36B | 24 | 44.7% |
| 2021 | JPY 2.17B | 22 | 50.5% |
| 2020 | JPY 2.07B | 21 | 62.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:1 on Aug 27, 2015.
Who owns Mani, Inc.
- Insiders 25.63%
- Institutions 24.54%
- Public & others 49.83%
- Shares outstanding 98.5M
- Free float 69.6M
Mani, Inc. company profile
- Company name
- Mani, Inc.
- Ticker
- MNICF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 4,140
- Fiscal year end
- August
- Address
- 8-3 Kiyohara Industrial Park, Utsunomiya, Japan, 321-3231
- Phone
- 81 2 8667 1811
- Website
- mani.co.jp
About Mani, Inc.
Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
Mani, Inc. management
7- Mr. Masaya WatanabeCEO, President, Representative Executive Officer & Director · born 1958
- Mr. Masahiko SaitoChairperson of Board of Executive Officers & GM of Technical Fellow · born 1967
- Takayuki YamamotoManaging Executive Officer, Chief Risk Management Officer, Head of Corporate Planning Office & CFO · born 1965
- Mr. Kentaro InatomiAdministrative Officer & Department Head of Global Operations Dept. · born 1968
- Shuichi KuritaSr Mng Exec. Offcr, Hd of Bus Div, Ofc & Head of Human Resources Dept. · born 1961
- Mr. Kazuo Takahashi M.Sc.MD & Director · born 1955
- Mr. Tomomi KosakaManaging Exec Officer, Head of Operations & Production and GM of Production · born 1961